Global incidence of multidrug-resistant tuberculosis

被引:378
|
作者
Zignol, Matteo [1 ]
Hosseini, Mehran S. [1 ]
Wright, Abigail [1 ]
Lambregts-van Weezenbeek, Catharina [1 ]
Nunn, Paul [1 ]
Watt, Catherine J. [1 ]
Williams, Brian G. [1 ]
Dye, Christopher [1 ]
机构
[1] World Hlth Org, Stop TB Dept, CH-1211 Geneva, Switzerland
来源
JOURNAL OF INFECTIOUS DISEASES | 2006年 / 194卷 / 04期
关键词
D O I
10.1086/505877
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The global number of incident cases of multidrug-resistant (MDR) tuberculosis (TB) in 2000 was estimated to be 272,906 (95% confidence interval [CI], 184,948-414,295). For accurate planning of TB control programs, this estimate and others have been revised using data from additional countries and by including in the model previously treated TB cases, which had not been accounted for in the previous analysis. Methods. Multiple logistic regression was used to identify variables that were predictive of MDR-TB frequency among new and previously treated cases surveyed in 90 and 77 countries, respectively. These variables were then used to estimate MDR-TB frequencies in countries that had not been surveyed. Results. The total number of MDR-TB cases estimated to have occurred worldwide in 2004 is 424,203 (95% CI, 376,019-620,061), or 4.3% (95% CI, 3.8%-6.1%) of all new and previously treated TB cases. In the same year, 181,408 (95% CI, 135,276-319,017) MDR-TB cases were estimated to have occurred among previously treated TB cases alone. Three countries-China, India, and the Russian Federation-accounted for 261,362 (95% CI, 180,779-414,749) MDR-TB cases, or 62% of the estimated global burden. Conclusions. These updated sets of estimates incorporating previously treated TB cases call for an urgent plan to expand appropriate diagnostic and treatment services for patients with MDR-TB in low-resource settings.
引用
收藏
页码:479 / 485
页数:7
相关论文
共 50 条
  • [21] MULTIDRUG-RESISTANT TUBERCULOSIS
    GILLESPIE, SH
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1995, 53 (07): : 305 - 307
  • [22] Multidrug-resistant tuberculosis
    Keertan Dheda
    Fuad Mirzayev
    Daniela Maria Cirillo
    Zarir Udwadia
    Kelly E. Dooley
    Kwok-Chiu Chang
    Shaheed Vally Omar
    Anja Reuter
    Tahlia Perumal
    C. Robert Horsburgh
    Megan Murray
    Christoph Lange
    Nature Reviews Disease Primers, 10
  • [23] Multidrug-resistant tuberculosis
    Seaworth, BJ
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (01) : 73 - +
  • [24] Global action against multidrug-resistant tuberculosis - Reply
    Heymann, SJ
    Brewer, TF
    Wilson, ME
    Fineberg, HV
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (01): : 54 - 55
  • [25] Clinical implications of the global multidrug-resistant tuberculosis epidemic
    Kumar, Kartik
    Abubakar, Ibrahim
    CLINICAL MEDICINE, 2016, 16 (06) : 565 - 570
  • [26] The need for global action against multidrug-resistant tuberculosis
    Heymann, SJ
    Brewer, TF
    Wilson, ME
    Fineberg, HV
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (22): : 2138 - 2140
  • [27] Global burden of multidrug-resistant tuberculosis in children and adolescents
    Zhong, Yanyan
    Xie, Huiru
    Cai, Fucheng
    Liu, Miao
    Gan, Hui
    Tang, Zhuo
    Bai, Yan
    PEDIATRIC RESEARCH, 2025,
  • [28] Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
    Gandhi, Neel R.
    Nunn, Paul
    Dheda, Keertan
    Schaaf, H. Simon
    Zignol, Matteo
    van Soolingen, Dick
    Jensen, Paul
    Bayona, Jaime
    LANCET, 2010, 375 (9728): : 1830 - 1843
  • [29] MULTIDRUG-RESISTANT TUBERCULOSIS - REPLY
    EDLIN, BR
    TOKARS, JI
    CASTRO, KG
    DOOLEY, SW
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16): : 1174 - 1174
  • [30] Treatment of multidrug-resistant tuberculosis
    Colebunders, R
    Apers, L
    Shamputa, IC
    LANCET, 2004, 363 (9416): : 1240 - 1240